Skip to main content
. 2019 Apr 25;8(9):e012029. doi: 10.1161/JAHA.119.012029

Figure 1.

Figure 1

Enrollment of patients, aged ≥65 years, with nonvalvular atrial fibrillation (AF). From January 1, 2010, to December 31, 2017, this study evaluated a total of 7687 patients with hemoglobin ≥10 g/dL and 669 patients with hemoglobin <10 g/dL. NOAC indicates non–vitamin K antagonist oral anticoagulant.